Takamichi Yokoe
7PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Apr 26, 2025
MUC1-C dependency in drug resistant HR+/HER2- breast cancer identifies a new target for antibody-drug conjugate treatment.Ayako Nakashoji, Atrayee Bhattacharya, Hiroki Ozawa
|Feb 11, 2025
Efficacy and safety of dose-dense chemotherapy for early-stage breast cancer under prophylactic pegfilgrastim administration: a systematic review and meta-analysis from clinical practice guidelines for the use of G-CSF 2022.Takamichi Yokoe, Tetsuhiro Yoshinami, Kazuki Nozawa
|Apr 02, 2021
Genomic profiling reveals heterogeneous populations of ductal carcinoma in situ of the breast.Satoi Nagasawa, Yuta Kuze, Ichiro Maeda
|Jan 03, 2021
Clinical benefit of treatment after trastuzumab emtansine for HER2-positive metastatic breast cancer: a real-world multi-centre cohort study in Japan (WJOG12519B).Takamichi Yokoe, Sasagu Kurozumi, Kazuki Nozawa
|May 26, 2020
Impact of neoadjuvant and adjuvant chemotherapy on invasive lobular carcinoma: A propensity score-matched analysis of SEER data.Rurina Watanuki, Tetsu Hayashida, Takamichi Yokoe
|Oct 19, 2018
Effectiveness of Antiemetic Regimens for Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Network Meta-Analysis.Takamichi Yokoe, Tetsu Hayashida, Aiko Nagayama
Pageof 2
